Augtyro is the only FDA-approved treatment option for NTRK-positive tumors studied in both TKI-naïve and TKI-pretreated patients across solid tumors
Fischer MVL envisages to offer a diverse portfolio of diagnostic solutions
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes
Sapala has a strong customer base including innovator Pharma, CDMOs & diagnostic companies
The primary endpoint in the final analysis was assessed by change in the North Star Ambulatory Assessment at one year after treatment
Accelerating sustainability in Indian pharma industry
Prior to taking charge at the Union Health Ministry, Jadhav planted a sapling at his residence
his strategic collaboration with BluSim Tech marks a significant milestone in Fischer MVL's journey towards expanding its healthcare portfolio
The new brand identity embodies Neuland's unwavering commitment to innovation, integrity, collaboration, and progress
Subscribe To Our Newsletter & Stay Updated
